In NB nuclear FOXO3 predicts adverse clinical outcome, promotes tumor angiogenesis [18], and mediates chemoprotection in the high-stage NB cell lines NB1, NB4, and NB8. The gene discussed is FOXO3; the disease is neuroblastoma.